Optimal rhCG(Ovidrel®) Dose in Poor Responder During IVF and ICSI Cycles
NCT01406600
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
70
Enrollment
OTHER
Sponsor class
Conditions
in Vitro Fertilization
Poor Responder
Interventions
DRUG:
recombinant hCG (Ovidrel®)
Sponsor
Seoul National University Hospital